UNSPSC 51283205: Oleandomycin

This classification denotes a macrolide antibiotic with the molecular formula C35H61NO12, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P8ZQ646136, chemically known as 12-((2,6-didesoxy-3-o-methyl-alpha-k-arabino-hexopyranosyl)oxy)-8-hydroxy-5,7,8,11,13,15-hexamethyl-14-((3,4,6-tridesoxy-3-dimethylamino-beta-d-xylo-hexopyranosyl)oxy)-1,9-dioxaspiro(2.13)hexadecan-4,10-dion but generally known as oleandomycin, which bears US NIH Compound Identifier 19822.

UNSPSC 51283205 Oleandomycin is a Commodity code for a specific antibiotic pharmaceutical product, but recent state and local procurement activity under this code shows little direct alignment with oleandomycin itself. State and local governments procure antibiotics and other pharmaceuticals through cooperative purchasing arrangements and direct supply contracts, typically for emergency medical supplies, public health stockpiles, and community health programs. The issuing bodies include state health departments and county health authorities executing purchases through piggyback contracts tied to multi-jurisdictional cooperative consortia and competitive bidding processes.

Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026 for $2,999,999.11 over the full contract term (12 months with renewal options for years 2 and 3), supplying Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets under IFB process. Seminole County, Florida issued an IFB (IFB60459723LAS) in June 2026 seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually for quarterly delivery to the Seminole County Community Health Building in Sanford, with a two-year initial term and one-year renewal option. Recent activity concentrates in Florida and Illinois; the procurement pattern reflects state and local reliance on cooperative purchasing vehicles and fixed-price competitive bids for pharmaceutical and medical-supply inventory replenishment rather than specialized narrow-spectrum antibiotic procurement.